{"id":"W4411293910","doi":"10.2337/db25-1863-lb","title":"1863-LB: The Confidence Trial—Efficacy/Safety of Combining Finerenone with Empagliflozin in People with Chronic Kidney Disease and Type 2 Diabetes","year":2025,"lang":"en","type":"article","venue":"Diabetes","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Empagliflozin; Medicine; Type 2 diabetes; Kidney disease; Diabetes mellitus; Internal medicine; Confidence interval; Disease; Endocrinology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002043321,0.001212587,0.002172003,0.0003789401,0.0003646132,0.001092319,0.000733799,0.001722854,0.0108856],"category_scores_gemma":[0.002931061,0.0004260998,0.00215869,0.0003957172,0.0008604369,0.0009271235,0.0006413834,0.00257182,0.00109349],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004683837,"about_ca_system_score_gemma":0.000833438,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001337586,"about_ca_topic_score_gemma":0.00191505,"domain_scores_codex":[0.9992224,0.0003856787,0.000083354,0.0001516935,0.00006761965,0.00008915517],"domain_scores_gemma":[0.9990045,0.0002679184,0.0002834639,0.0000892418,0.00008390794,0.0002709349],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9817395,0.001764701,0.001457139,0.0008365513,0.0009933951,0.00002376367,0.00002697938,0.0001795601,0.0008395368,0.0001812887,0.00181507,0.01014244],"study_design_scores_gemma":[0.9694351,0.02446619,0.003062109,0.00007151765,0.001090831,0.00003431625,0.00001570998,0.0003151654,0.0001745595,0.0001307044,0.001190441,0.00001337698],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9642664,0.01137097,0.0009349844,0.002245577,0.0009887674,0.004462267,0.005706089,0.0002962115,0.009728593],"genre_scores_gemma":[0.9782678,0.002874529,0.001716904,0.003197148,0.0009689089,0.003801512,0.00485426,0.00003018031,0.004288873],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0108856,"threshold_uncertainty_score":0.03641593,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01120939176061852,"score_gpt":0.247504191073659,"score_spread":0.2362947993130405,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}